Zyversa Therapeutics Announces Share Purchase Agreement for up to $10 Million in Partnership With Williamsburg Venture Holdings to Fund Clinical Development of Cholesterol Efflux Mediator™ Var 200

THOMSON REUTERS
25 Jun

Zyversa Therapeutics Announces Share Purchase Agreement for up to $10 Million in Partnership With Williamsburg Venture Holdings to Fund Clinical Development of Cholesterol Efflux Mediator™ Var 200

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10